PTGS2 and glioblastoma: Thus, the main objective of the present study was to evaluate the ability of the alkylating agent TMZ to influence COX-2 expression and activity in two GBM cell lines, i.e., T98G and U251MG, showing different sensitivity to TMZ, COX-2 expression level, and MGMT status.